Hasil Pencarian - Gitika Panicker

  • Menampilkan 1 - 10 hasil dari 10
Perbaiki Hasil
  1. 1
    Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach.

    Sensitive and specific peak detection for SELDI-TOF mass spectrometry using a wavelet/neural-network based approach. oleh Vincent A Emanuele, Gitika Panicker, Brian M Gurbaxani, Jin-Mann S Lin, Elizabeth R Unger

    Diterbitkan 2012-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity

    Delayed dosing intervals for quadrivalent human papillomavirus vaccine do not reduce antibody avidity oleh Allison M. Brady, Emmanuel B. Walter, Lauri E. Markowitz, Elizabeth R. Unger, Gitika Panicker

    Diterbitkan 2020-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study

    Antibody persistence after a single dose of quadrivalent HPV vaccine and the effect of a dose of nonavalent vaccine given 3-8 years later – an exploratory study oleh Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, Manale Ouakki, Elizabeth R. Unger

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials

    Priming effect of bivalent and quadrivalent vaccine for HPV 31/33/45/52: an exploratory analysis from two clinical trials oleh Chantal Sauvageau, Gitika Panicker, Elizabeth R. Unger, Gaston De Serres, John Schiller, Manale Ouakki, Vladimir Gilca

    Diterbitkan 2020-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials

    Long intervals between two doses of HPV vaccines and magnitude of the immune response: a post hoc analysis of two clinical trials oleh Vladimir Gilca, Chantal Sauvageau, Gitika Panicker, Gaston De Serres, John Schiller, Manale Ouakki, Elisabeth R. Unger

    Diterbitkan 2019-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010

    Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003–2010 oleh Emiko Y. Petrosky, Susan Hariri, Lauri E. Markowitz, Gitika Panicker, Elizabeth R. Unger, Eileen F. Dunne

    Diterbitkan 2015-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route

    Enhanced Immunogenicity of Adjuvanted Microparticulate HPV16 Vaccines Administered via the Transdermal Route oleh Trinh Phuong Vo, Gitika Panicker, Kimberly Braz-Gomes, Ashwin C. Parenky, Ira Rajbhandari, Mangalathu S. Rajeevan, Elizabeth R. Unger, Martin J. D’Souza, Mohammad N. Uddin

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58

    WHO International Standards for antibodies to HPV6 HPV11 HPV31 HPV33 HPV45 HPV52 and HPV58 oleh Troy J. Kemp, Gitika Panicker, Carina Eklund, Jianhui Nie, Youchun Wang, Simon Beddows, Peter Rigsby, Weijin Huang, Joakim Dillner, Elizabeth R. Unger, Ligia A. Pinto, Dianna E. Wilkinson, the collaborative study participants

    Diterbitkan 2024-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure

    Duration of Cellular and Humoral Responses after Quadrivalent Human Papillomavirus Vaccination in Healthy Female Adults with or without Prior Type 16 and/or 18 Exposure oleh Lilin Lai, Kevin Ault, Nadine Rouphael, Allison Beck, Briyana Domjahn, Yongxian Xu, Evan J. Anderson, Andrew Cheng, Aya Nakamura, Rebecca J. Hoagland, Colleen Kelley, Srilatha Edupuganti, Karen Mask, Mirjana Nesin, Elizabeth R. Unger, Gitika Panicker, Hagit David, Mark J. Mulligan

    Diterbitkan 2020-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV vaccine

    Impact of age at vaccination and cervical HPV infection status on binding and neutralizing antibody titers at 10 years after receiving single or higher doses of quadrivalent HPV va... oleh Neerja Bhatla, Richard Muwonge, Sylla G. Malvi, Smita Joshi, Usha Rani Reddy Poli, Eric Lucas, Pulikkottil O. Esmy, Yogesh Verma, Anand Shah, Eric Zomawia, Sharmila Pimple, Kasturi Jayant, Sanjay Hingmire, Aruna Chiwate, Shachi Vashist, Gauravi Mishra, Radhika Jadhav, Maqsood Siddiqi, Devasena Anantharaman, Gitika Panicker, Julia Butt, Subha Sankaran, Thiraviam Pillai Rameshwari Ammal Kannan, Rintu Varghese, Purnima Kartha, M. Radhakrishna Pillai, Tim Waterboer, Martin Müller, Peter Sehr, Elizabeth R. Unger, Rengaswamy Sankaranarayanan, Partha Basu

    Diterbitkan 2023-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: